Vanguard Capital Management
BMRA icon

Vanguard Capital Management’s Biomerica BMRA Stock Holding History

Vanguard Capital Management’s Portfolio BMRA Stock Details BMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.5K Hold
14,514
– – ﹤0.01% 3997
2026
Q1 		$30.6K Buy
+14,514
New +$33.2K ﹤0.01% 3959

Other funds holding BMRA

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $1.54B AUM 30.1% 1-Year Est. Return

Vanguard Capital Management's BMRA Position: Q2 2026 in Review

Vanguard Capital Management held its Biomerica (BMRA) position steady in Q2 2026 at 14,514 shares worth $25.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3997.

Vanguard Capital Management first reported a position in BMRA in Q1 2026 and has held it in 2 quarters since. The position peaked at $30.6K in Q1 2026. 20 funds tracked by Wall St. Rank hold BMRA as of Q2 2026.

  • Vanguard Capital Management held 14,514 shares of Biomerica worth $25.5K as of Q2 2026.
  • Vanguard Capital Management left its Biomerica share count unchanged in Q2 2026.
  • Biomerica made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3997 holding.
  • Vanguard Capital Management first reported a position in Biomerica in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Capital Management's Biomerica position peaked at $30.6K in Q1 2026.
  • 20 funds tracked by Wall St. Rank held Biomerica as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.